Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.16 trillion and total revenue of $111.56 billion.
Market Cap
1.16T
Revenue
111.56B
Profits
-41.04B
PE Ratio
n/a
Profit Margin
-36.79%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.88B | 0.97% | 619,105 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.27B | -0.44% | 395,675 | 14.92B |
| 3 | ARGX | argenx SE | 50.91B | -2.56% | 272,785 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.04B | 0.14% | 427,853 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.27B | 0.70% | 126,328 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.60B | 2.00% | 951,107 | - |
| 7 | RPRX | Royalty Pharma plc | 30.31B | 1.82% | 1,367,198 | 2.44B |
| 8 | INSM | Insmed Incorporated | 25.62B | 1.91% | 4,884,953 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.34B | -1.45% | 621,783 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.91B | -0.61% | 2,403,320 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 20.07B | -5.03% | 5,060,591 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.62B | -0.92% | 757,330 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.50B | -2.09% | 1,468,367 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.09B | 2.25% | 274,080 | 998.25M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.62B | -0.58% | 1,170,527 | - |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.49B | 1.39% | 592,399 | 4.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.57B | 5.03% | 2,023,679 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.81B | 3.03% | 1,790,957 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.78B | 2.02% | 594,072 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 4.71% | 429,479 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.94B | 1.48% | 256,171 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.03B | -0.96% | 1,004,940 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.33B | 1.10% | 1,095,841 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.63B | 0.34% | 586,896 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.54B | 2.51% | 1,032,159 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.45B | -1.20% | 279,144 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.34B | 2.11% | 180,904 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.48B | -0.25% | 6,739,077 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.16B | 0.70% | 188,375 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -3.36% | 1,539,828 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.87B | 0.87% | 800,965 | - |
| 32 | KYMR | Kymera Therapeutics, Inc. | 7.03B | 2.36% | 140,513 | 51.48M |
| 33 | TECH | Bio-Techne Corporation | 6.94B | -6.56% | 2,098,647 | 1.21B |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.82B | 4.58% | 5,127,410 | 569.61M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.71B | 2.89% | 348,061 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.61B | 2.86% | 223,171 | 74.06M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.58B | 5.08% | 732,593 | 217.17M |
| 38 | CGON | CG Oncology, Inc. | 6.50B | 2.23% | 328,814 | 5.07M |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.21B | -0.16% | 299,448 | - |
| 40 | CORT | Corcept Therapeutics Incorporated | 6.18B | 12.59% | 1,301,112 | 769.10M |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.13B | -1.45% | 642,149 | 827.11M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.04% | 1,457,887 | 15.00M |
| 43 | TGTX | TG Therapeutics, Inc. | 6.09B | 1.01% | 981,193 | 700.35M |
| 44 | BLTE | Belite Bio, Inc | 6.08B | -0.62% | 112,805 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.98B | 1.44% | 858,815 | - |
| 46 | CELC | Celcuity Inc. | 5.94B | -1.39% | 370,933 | - |
| 47 | IMVT | Immunovant, Inc. | 5.91B | 1.41% | 747,353 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.84B | -1.01% | 531,910 | - |
| 49 | LEGN | Legend Biotech Corporation | 5.37B | 2.80% | 1,792,771 | 1.14B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.36B | 0.89% | 497,053 | 7.50M |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.04% | 10,241,639 | 1.11B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.14B | 0.83% | 529,830 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -2.17% | 208,101 | 1.34M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.48B | 0.68% | 114,562 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.45B | 4.08% | 209,802 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.35B | -2.61% | 1,199,873 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.15B | 4.27% | 1,088,578 | 536.20M |
| 58 | CAI | Caris Life Sciences, Inc. | 4.03B | -14.92% | 5,110,183 | 907.29M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.38% | 639,392 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.82B | -1.28% | 468,901 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.05% | 1,878,400 | 596.96M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | 0.60% | 569,929 | 1.10B |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.67B | 0.86% | 553,964 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.62B | -1.03% | 528,710 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.59B | 6.00% | 1,881,090 | 62.38M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.55B | 1.35% | 53,139 | 803.79M |
| 67 | ERAS | Erasca, Inc. | 3.23B | 0.19% | 1,730,409 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.21B | 2.22% | 589,564 | 164.01M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.17B | 1.29% | 256,940 | 236.00M |
| 70 | ALMS | Alumis Inc. | 3.14B | 4.85% | 371,861 | 24.05M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.12B | 1.03% | 490,901 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.07B | 0.98% | 365,893 | - |
| 73 | KLRA | Kailera Therapeutics, Inc. | 2.82B | -2.29% | 155,295 | - |
| 74 | VERA | Vera Therapeutics, Inc. | 2.78B | 5.50% | 354,613 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | 7.30% | 570,423 | 535.08M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.07% | 839,826 | 285.01M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.73B | 5.56% | 2,387,266 | 415.62M |
| 78 | GPCR | Structure Therapeutics Inc. | 2.68B | -0.32% | 297,418 | - |
| 79 | IRON | Disc Medicine, Inc. | 2.67B | 1.85% | 417,580 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.66B | 3.17% | 720,344 | - |
| 81 | NKTR | Nektar Therapeutics | 2.61B | -1.49% | 403,796 | 55.63M |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | -1.27% | 445,407 | 670.00M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.55B | 1.53% | 704,110 | 865.00K |
| 84 | IMNM | Immunome, Inc. | 2.53B | -1.54% | 543,670 | 4.02M |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.52B | 2.03% | 471,072 | 225.27M |
| 86 | RLAY | Relay Therapeutics, Inc. | 2.51B | 1.16% | 1,102,590 | 10.68M |
| 87 | NBTX | Nanobiotix S.A. | 2.50B | 8.46% | 42,987 | 38.27M |
| 88 | KOD | Kodiak Sciences Inc. | 2.46B | -0.28% | 178,204 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.43B | 5.43% | 760,456 | - |
| 90 | ZLAB | Zai Lab Limited | 2.28B | 3.71% | 413,848 | 453.28M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -5.91% | 1,010,588 | - |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.20B | 4.95% | 978,682 | - |
| 93 | PHVS | Pharvaris N.V. | 2.15B | 5.15% | 84,721 | - |
| 94 | TYRA | Tyra Biosciences, Inc. | 2.14B | 3.23% | 292,754 | - |
| 95 | GENB | Generate Biomedicines, Inc. | 2.12B | 7.62% | 295,012 | 30.30M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.44% | 740,546 | 298.30M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.03B | 1.09% | 1,802,943 | 52.04M |
| 98 | NTLA | Intellia Therapeutics, Inc. | 2.02B | 3.22% | 2,558,361 | 66.09M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | -0.63% | 1,431,823 | 2.18B |
| 100 | STOK | Stoke Therapeutics, Inc. | 1.97B | -2.43% | 479,224 | 32.08M |
| 101 | ADMA | ADMA Biologics, Inc. | 1.96B | 0.48% | 2,352,730 | 509.86M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.95B | 5.75% | 324,574 | - |
| 103 | AAPG | Ascentage Pharma Group International | 1.92B | -0.28% | 2,473 | 82.08M |
| 104 | MESO | Mesoblast Limited | 1.90B | 1.94% | 87,696 | 65.38M |
| 105 | TSHA | Taysha Gene Therapies, Inc. | 1.90B | -3.58% | 1,508,093 | 7.47M |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 2.89% | 706,343 | 217.17M |
| 107 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 3.04% | 171,708 | 1.20B |
| 108 | ANAB | AnaptysBio, Inc. | 1.86B | -2.78% | 570,161 | 232.39M |
| 109 | OCS | Oculis Holding AG | 1.84B | 2.27% | 546,343 | 1.40M |
| 110 | ZYME | Zymeworks Inc. | 1.81B | 3.43% | 377,963 | 81.26M |
| 111 | QURE | uniQure N.V. | 1.80B | -1.79% | 1,129,795 | 18.09M |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.80B | 1.15% | 162,725 | 20.00M |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.77B | 1.69% | 335,863 | 899.11M |
| 114 | VRDN | Viridian Therapeutics, Inc. | 1.76B | 1.42% | 1,141,536 | 70.92M |
| 115 | MBX | MBX Biosciences, Inc. | 1.76B | -0.16% | 396,703 | - |
| 116 | CAPR | Capricor Therapeutics, Inc. | 1.72B | -5.39% | 955,539 | 11.13M |
| 117 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -4.67% | 104,699 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 1.27% | 308,495 | 66.05M |
| 119 | INVA | Innoviva, Inc. | 1.71B | 1.65% | 356,733 | 420.69M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 2.76% | 423,270 | 71.78M |
| 121 | VCEL | Vericel Corporation | 1.67B | -0.94% | 315,115 | 292.09M |
| 122 | NUVB | Nuvation Bio Inc. | 1.66B | -1.45% | 2,445,478 | 143.05M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | -1.59% | 8,224,718 | 66.41M |
| 124 | INBX | Inhibrx Biosciences, Inc. | 1.63B | 2.69% | 340,287 | 1.30M |
| 125 | IOVA | Iovance Biotherapeutics, Inc. | 1.62B | 2.11% | 4,750,662 | 285.61M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | -1.05% | 298,360 | 42.95M |
| 127 | ARDX | Ardelyx, Inc. | 1.59B | -2.57% | 5,387,267 | 427.68M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.57B | -0.85% | 453,384 | 65.50M |
| 129 | ATAI | AtaiBeckley Inc. | 1.57B | 2.89% | 3,194,987 | 3.49M |
| 130 | NVAX | Novavax, Inc. | 1.55B | -2.13% | 2,683,125 | 596.34M |
| 131 | URGN | UroGen Pharma Ltd. | 1.49B | 2.85% | 482,015 | 140.49M |
| 132 | IMCR | Immunocore Holdings plc | 1.48B | -0.61% | 93,079 | 412.81M |
| 133 | ABCL | AbCellera Biologics Inc. | 1.48B | -2.32% | 4,834,187 | 79.21M |
| 134 | MAZE | Maze Therapeutics, Inc. | 1.48B | 3.49% | 490,776 | 20.00M |
| 135 | PGEN | Precigen, Inc. | 1.47B | 1.72% | 1,381,096 | 9.68M |
| 136 | DMRA | Damora Therapeutics, Inc. | 1.45B | 3.94% | 306,743 | - |
| 137 | IMTX | Immatics N.V. | 1.44B | -5.97% | 1,240,866 | 43.00M |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.39% | 1,263,360 | 73.62M |
| 139 | MPLT | MapLight Therapeutics, Inc. | 1.40B | 2.18% | 113,958 | - |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.40B | -4.78% | 551,186 | - |
| 141 | GHRS | GH Research PLC | 1.36B | 2.04% | 69,119 | - |
| 142 | FTRE | Fortrea Holdings Inc. | 1.36B | -1.37% | 485,289 | 2.71B |
| 143 | BHVN | Biohaven Ltd. | 1.36B | -2.07% | 1,312,812 | - |
| 144 | WVE | Wave Life Sciences Ltd. | 1.35B | 3.02% | 4,754,760 | 71.80M |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.34B | 1.48% | 691,131 | - |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -0.41% | 139,262 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | -0.88% | 791,138 | - |
| 148 | SVRA | Savara Inc. | 1.31B | 1.87% | 662,925 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.30B | 3.88% | 280,544 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.23B | -0.89% | 112,605 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.23B | 7.05% | 142,729 | - |
| 152 | DBVT | DBV Technologies S.A. | 1.21B | -2.25% | 127,089 | 5.74M |
| 153 | SLS | SELLAS Life Sciences Group, Inc. | 1.20B | 23.75% | 23,078,516 | - |
| 154 | OLMA | Olema Pharmaceuticals, Inc. | 1.20B | -1.83% | 605,476 | - |
| 155 | ZBIO | Zenas BioPharma, Inc. | 1.18B | 3.76% | 245,883 | 10.00M |
| 156 | IVA | Inventiva S.A. | 1.16B | -2.61% | 66,205 | 7.94M |
| 157 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -5.90% | 1,085,733 | 204.73M |
| 158 | EYPT | EyePoint, Inc. | 1.12B | -1.54% | 481,484 | 7.61M |
| 159 | SEPN | Septerna, Inc. | 1.12B | -0.16% | 151,165 | 72.26M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.24% | 2,663,551 | 69.64M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.08B | -0.66% | 74,360 | 8.28M |
| 162 | OMER | Omeros Corporation | 1.06B | -0.47% | 1,492,714 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 1.52% | 625,757 | 204.89M |
| 164 | MNKD | MannKind Corporation | 997.91M | -1.52% | 2,193,801 | 360.78M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 988.86M | -0.37% | 541,196 | - |
| 166 | DSGN | Design Therapeutics, Inc. | 975.58M | -1.08% | 334,187 | - |
| 167 | PHAR | Pharming Group N.V. | 940.29M | 0.92% | 6,171 | 369.49M |
| 168 | MGTX | MeiraGTx Holdings plc | 928.51M | 2.45% | 189,348 | 81.39M |
| 169 | XNCR | Xencor, Inc. | 920.84M | -0.16% | 275,431 | 97.36M |
| 170 | GERN | Geron Corporation | 920.58M | 2.50% | 17,844,516 | 196.12M |
| 171 | LBRX | LB Pharmaceuticals Inc | 914.75M | 2.47% | 101,907 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 914.19M | 0.77% | 2,895,976 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 891.59M | 1.46% | 418,809 | 13.73M |
| 174 | ANNX | Annexon, Inc. | 889.66M | -0.18% | 1,005,628 | - |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 883.00M | -3.40% | 568,051 | - |
| 176 | VOR | Vor Biopharma Inc. | 878.89M | -1.52% | 449,895 | - |
| 177 | SPTX | Seaport Therapeutics, Inc. | 871.25M | 3.01% | 373,066 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 862.22M | 1.49% | 187,664 | 109.78M |
| 179 | ABSI | Absci Corporation | 859.82M | 2.99% | 2,121,225 | 1.84M |
| 180 | DRTS | Alpha Tau Medical Ltd. | 855.45M | -1.62% | 596,507 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 845.86M | -0.35% | 869,651 | 191.45M |
| 182 | KURA | Kura Oncology, Inc. | 836.25M | -2.69% | 1,344,090 | 71.64M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 833.13M | -2.78% | 916,187 | 84.28M |
| 184 | ODTX | Odyssey Therapeutics, Inc. | 828.38M | -1.90% | 164,969 | 2.98M |
| 185 | EVMN | Evommune, Inc. | 828.06M | 1.32% | 145,098 | 10.00M |
| 186 | AURA | Aura Biosciences, Inc. | 827.61M | 0.95% | 311,934 | - |
| 187 | CTMX | CytomX Therapeutics, Inc. | 813.12M | -3.74% | 1,636,889 | 35.54M |
| 188 | ANRO | Alto Neuroscience, Inc. | 804.81M | -6.78% | 279,369 | - |
| 189 | ALLO | Allogene Therapeutics, Inc. | 803.91M | 1.30% | 3,983,352 | 22.00K |
| 190 | DRUG | Bright Minds Biosciences Inc. | 803.33M | 0.12% | 94,826 | - |
| 191 | SGP | SpyGlass Pharma, Inc. | 792.88M | -1.74% | 8,847 | - |
| 192 | RLMD | Relmada Therapeutics, Inc. | 771.98M | -1.21% | 712,139 | - |
| 193 | SLDB | Solid Biosciences Inc. | 701.95M | -7.64% | 1,049,378 | - |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 699.02M | 2.56% | 1,526,150 | 8.37M |
| 195 | TENX | Tenax Therapeutics, Inc. | 698.89M | -2.47% | 259,590 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 664.27M | -0.41% | 23,788 | 117.05M |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 662.68M | 1.45% | 661,935 | 122.29M |
| 198 | KYTX | Kyverna Therapeutics, Inc. | 658.57M | 6.35% | 1,291,615 | - |
| 199 | EIKN | Eikon Therapeutics, Inc. | 655.62M | 5.03% | 280,594 | - |
| 200 | STRO | Sutro Biopharma, Inc. | 654.43M | -3.45% | 161,378 | 102.48M |
| 201 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 644.26M | -0.98% | 167,366 | - |
| 202 | CADL | Candel Therapeutics, Inc. | 631.59M | -1.15% | 1,217,973 | - |
| 203 | ARVN | Arvinas, Inc. | 628.76M | 1.83% | 429,677 | 89.40M |
| 204 | CBIO | Crescent Biopharma, Inc. | 627.36M | 2.28% | 116,406 | 11.88M |
| 205 | TRAX | First Tracks Biotherapeutics, Inc. | 621.31M | 0.39% | 165,653 | - |
| 206 | FBRX | Forte Biosciences, Inc. | 620.09M | 0.66% | 77,733 | - |
| 207 | RIGL | Rigel Pharmaceuticals, Inc. | 607.24M | 11.75% | 608,050 | 299.77M |
| 208 | PRME | Prime Medicine, Inc. | 600.55M | 0.76% | 1,325,966 | 4.03M |
| 209 | CRMD | CorMedix Inc. | 589.49M | 0.07% | 694,187 | 311.71M |
| 210 | ALT | Altimmune, Inc. | 584.54M | -2.27% | 2,320,114 | 36.00K |
| 211 | CABA | Cabaletta Bio, Inc. | 572.30M | -3.31% | 4,581,118 | - |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 564.73M | 3.66% | 776,248 | 151.40M |
| 213 | VALN | Valneva SE | 562.56M | -0.82% | 27,824 | 205.07M |
| 214 | IMMX | Immix Biopharma, Inc. | 552.92M | -2.16% | 389,675 | - |
| 215 | ANL | Adlai Nortye Ltd. | 552.00M | 4.94% | 20,394 | 5.00M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 548.90M | 1.55% | 181,248 | 88.24M |
| 217 | AGMB | AgomAb Therapeutics NV | 547.15M | -8.03% | 31,224 | - |
| 218 | CLYM | Climb Bio, Inc. | 544.08M | 1.97% | 263,765 | - |
| 219 | PROK | ProKidney Corp. | 535.98M | -0.28% | 353,094 | 893.00K |
| 220 | TECX | Tectonic Therapeutic, Inc. | 532.11M | 0.86% | 131,774 | - |
| 221 | MDXG | MiMedx Group, Inc. | 527.27M | - | 978,864 | 389.42M |
| 222 | AVTX | Avalo Therapeutics, Inc. | 525.20M | -1.40% | 823,995 | 59.00K |
| 223 | XOMA | XOMA Royalty Corporation | 523.78M | 0.04% | 54,166 | 48.56M |
| 224 | RGNX | REGENXBIO Inc. | 523.40M | -0.98% | 1,286,420 | 170.44M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 522.66M | 2.34% | 49,018 | - |
| 226 | STTK | Shattuck Labs, Inc. | 507.91M | 1.51% | 217,132 | 1.00M |
| 227 | NGNE | Neurogene Inc. | 501.08M | 0.54% | 77,701 | 925.00K |
| 228 | PRTA | Prothena Corporation plc | 497.36M | 0.74% | 182,347 | 57.94M |
| 229 | ASMB | Assembly Biosciences, Inc. | 496.33M | 1.33% | 31,004 | 71.10M |
| 230 | OCGN | Ocugen, Inc. | 495.93M | -0.34% | 2,513,952 | 4.47M |
| 231 | UPB | Upstream Bio, Inc. | 489.78M | 0.56% | 388,969 | 3.32M |
| 232 | OVID | Ovid Therapeutics Inc. | 485.37M | -2.26% | 1,370,519 | 7.12M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.07M | 0.79% | 53,007 | - |
| 234 | FULC | Fulcrum Therapeutics, Inc. | 463.10M | -0.14% | 201,193 | 80.00M |
| 235 | AUTL | Autolus Therapeutics plc | 459.10M | 7.81% | 1,604,808 | 75.39M |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 456.21M | 1.93% | 335,798 | - |
| 237 | SGMT | Sagimet Biosciences Inc. | 455.11M | -3.66% | 415,466 | - |
| 238 | LYEL | Lyell Immunopharma, Inc. | 447.63M | -0.34% | 21,769 | 31.00K |
| 239 | ZURA | Zura Bio Limited | 446.41M | -0.95% | 213,072 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 445.56M | -4.53% | 264,976 | 16.72M |
| 241 | ADCT | ADC Therapeutics SA | 438.81M | 0.58% | 750,532 | 79.18M |
| 242 | REPL | Replimune Group, Inc. | 436.81M | 29.34% | 12,972,208 | - |
| 243 | PRTC | PureTech Health plc | 432.38M | 1.04% | 7,547 | 4.66M |
| 244 | LRMR | Larimar Therapeutics, Inc. | 423.84M | -1.21% | 504,520 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 419.24M | 20.03% | 10,910,405 | 34.86M |
| 246 | VSTM | Verastem, Inc. | 416.52M | 2.38% | 1,030,987 | 49.59M |
| 247 | IPSC | Century Therapeutics, Inc. | 413.91M | 0.22% | 449,648 | 109.16M |
| 248 | IVVD | Invivyd, Inc. | 411.48M | -2.35% | 650,503 | 53.43M |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 409.32M | -2.92% | 86,679 | 69.21M |
| 250 | MNPR | Monopar Therapeutics Inc. | 401.32M | -2.35% | 253,249 | - |
| 251 | RCKT | Rocket Pharmaceuticals, Inc. | 395.83M | -0.41% | 920,734 | - |
| 252 | BNTC | Benitec Biopharma Inc. | 395.47M | -2.49% | 35,443 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 391.35M | -0.82% | 157,114 | 9.01M |
| 254 | VTVT | vTv Therapeutics Inc. | 390.28M | -2.06% | 38,325 | 17.00K |
| 255 | VNDA | Vanda Pharmaceuticals Inc. | 389.08M | 0.78% | 645,325 | 217.78M |
| 256 | NAUT | Nautilus Biotechnology, Inc. | 376.15M | 1.02% | 368,870 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 372.13M | -15.45% | 729,690 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 360.11M | -0.07% | 114,713 | 227.18M |
| 259 | YDES | YD Bio Limited | 357.22M | -2.12% | 15,030 | 510.36K |
| 260 | CMPX | Compass Therapeutics, Inc. | 355.67M | 5.61% | 3,830,086 | 850.00K |
| 261 | SRZN | Surrozen, Inc. | 355.51M | 0.95% | 40,270 | 7.49M |
| 262 | GLSI | Greenwich LifeSciences, Inc. | 351.21M | 2.59% | 129,289 | - |
| 263 | IRD | Opus Genetics, Inc. | 349.87M | -5.41% | 966,363 | 11.98M |
| 264 | RZLT | Rezolute, Inc. | 348.92M | 1.21% | 609,012 | - |
| 265 | IMRX | Immuneering Corporation | 344.19M | 2.70% | 307,936 | - |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 336.77M | -1.11% | 89,228 | - |
| 267 | SLN | Silence Therapeutics plc | 333.00M | 3.83% | 27,752 | 839.00K |
| 268 | BCYC | Bicycle Therapeutics plc | 330.41M | 0.42% | 200,893 | 63.50M |
| 269 | NMRA | Neumora Therapeutics, Inc. | 327.93M | -5.53% | 1,527,231 | - |
| 270 | ARMP | Armata Pharmaceuticals, Inc. | 326.95M | -1.00% | 18,854 | 4.90M |
| 271 | ACHV | Achieve Life Sciences, Inc. | 324.23M | 1.67% | 834,960 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 323.66M | 0.18% | 1,742,937 | 14.54M |
| 273 | IKT | Inhibikase Therapeutics, Inc. | 322.95M | -1.30% | 580,215 | 1.00 |
| 274 | PALI | Palisade Bio, Inc. | 318.11M | -1.04% | 1,041,485 | - |
| 275 | LCTX | Lineage Cell Therapeutics, Inc. | 316.61M | -4.51% | 1,486,132 | 14.78M |
| 276 | NVCT | Nuvectis Pharma, Inc. | 315.92M | 9.27% | 126,750 | - |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 305.39M | 0.23% | 371,402 | 26.87M |
| 278 | NGEN | NervGen Pharma Corp. | 301.86M | - | 71,417 | - |
| 279 | CLLS | Cellectis S.A. | 301.58M | 0.25% | 20,126 | 75.11M |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 300.32M | -0.38% | 641,147 | - |
| 281 | NAGE | Niagen Bioscience, Inc. | 299.69M | -2.47% | 805,287 | 130.42M |
| 282 | TARA | Protara Therapeutics, Inc. | 292.92M | 3.30% | 323,444 | - |
| 283 | EDIT | Editas Medicine, Inc. | 283.93M | -1.02% | 563,648 | 38.69M |
| 284 | AVXL | Anavex Life Sciences Corp. | 283.58M | - | 530,085 | - |
| 285 | OABI | OmniAb, Inc. | 283.42M | 5.68% | 834,520 | 28.94M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 278.54M | 1.97% | 303,003 | - |
| 287 | ACIU | AC Immune SA | 274.79M | - | 207,544 | 4.62M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 273.37M | 7.46% | 558,902 | 114.70K |
| 289 | CHRS | Coherus Oncology, Inc. | 268.39M | 1.75% | 2,147,370 | 46.88M |
| 290 | CGEN | Compugen Ltd. | 268.06M | 0.18% | 97,101 | 72.76M |
| 291 | HELP | Cybin Inc. | 259.19M | 2.37% | 296,319 | - |
| 292 | HUMA | Humacyte, Inc. | 258.65M | 28.02% | 21,090,270 | 2.02M |
| 293 | ARTV | Artiva Biotherapeutics, Inc. | 253.84M | -3.39% | 333,300 | 251.00K |
| 294 | LENZ | LENZ Therapeutics, Inc. | 253.03M | 2.02% | 524,321 | 20.99M |
| 295 | VYGR | Voyager Therapeutics, Inc. | 251.35M | 0.24% | 315,615 | 36.49M |
| 296 | RNAC | Cartesian Therapeutics, Inc. | 250.18M | -2.13% | 59,795 | 1.78M |
| 297 | NERV | Minerva Neurosciences, Inc. | 249.68M | 1.70% | 168,513 | - |
| 298 | TRDA | Entrada Therapeutics, Inc. | 248.99M | -2.95% | 345,489 | 5.74M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 244.91M | 0.74% | 150,557 | 32.72M |
| 300 | FHTX | Foghorn Therapeutics Inc. | 244.25M | -1.89% | 58,698 | 28.22M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 242.69M | 25.26% | 4,641,031 | 7.15M |
| 302 | CAMP | Camp4 Therapeutics Corporation | 241.71M | 3.44% | 228,382 | 3.93M |
| 303 | ADAG | Adagene Inc. | 240.50M | -0.55% | 24,812 | 7.67M |
| 304 | ALEC | Alector, Inc. | 239.26M | -0.23% | 264,367 | 18.42M |
| 305 | NBP | NovaBridge Biosciences | 238.81M | 0.24% | 1,122,029 | - |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 237.78M | -2.56% | 95,231 | 44.64M |
| 307 | ARCT | Arcturus Therapeutics Holdings Inc. | 237.33M | 1.21% | 262,093 | 54.71M |
| 308 | KROS | Keros Therapeutics, Inc. | 232.70M | 0.94% | 127,890 | 244.06M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 232.10M | 5.64% | 10,421 | 19.39M |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 229.93M | -11.05% | 4,711,167 | 1.55M |
| 311 | CDXS | Codexis, Inc. | 227.70M | -1.38% | 648,643 | 78.09M |
| 312 | NKTX | Nkarta, Inc. | 227.51M | -3.05% | 524,180 | - |
| 313 | UNCY | Unicycive Therapeutics, Inc. | 225.88M | 3.55% | 525,477 | - |
| 314 | FATE | Fate Therapeutics, Inc. | 225.59M | -13.78% | 3,786,534 | 6.32M |
| 315 | MGNX | MacroGenics, Inc. | 222.46M | -0.57% | 1,145,074 | 149.50M |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 219.82M | 3.84% | 216,099 | 17.56M |
| 317 | CNTX | Context Therapeutics Inc. | 219.59M | -3.63% | 313,127 | - |
| 318 | DTIL | Precision BioSciences, Inc. | 217.52M | 2.80% | 243,232 | 45.07M |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 211.42M | 4.29% | 180,533 | - |
| 320 | CRBU | Caribou Biosciences, Inc. | 210.27M | 5.42% | 1,190,391 | 11.20M |
| 321 | MDWD | MediWound Ltd. | 209.23M | 0.93% | 32,985 | 16.96M |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 208.67M | -3.84% | 3,346,814 | 225.00K |
| 323 | ELTX | Elicio Therapeutics, Inc. | 208.43M | 7.39% | 166,744 | - |
| 324 | RNA | Atrium Therapeutics, Inc. | 204.02M | 0.08% | 52,232 | 18.62M |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 201.76M | 0.39% | 767,824 | 146.07M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 197.73M | 6.73% | 504,596 | - |
| 327 | TLSA | Tiziana Life Sciences Ltd | 193.99M | -2.56% | 252,309 | - |
| 328 | IFRX | InflaRx N.V. | 188.68M | 7.41% | 3,065,436 | 33.82K |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 187.27M | 4.04% | 157,074 | 2.00M |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 182.01M | 1.61% | 134,499 | - |
| 331 | PRQR | ProQR Therapeutics N.V. | 179.11M | 6.25% | 553,581 | 15.73M |
| 332 | ENLV | Enlivex Ltd. | 178.38M | -1.24% | 169,640 | - |
| 333 | IMUX | Immunic, Inc. | 176.88M | 9.12% | 340,622 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 176.29M | -3.40% | 1,742,733 | 150.71M |
| 335 | PLYX | Polaryx Therapeutics, Inc. | 166.79M | 7.41% | 59,875 | - |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 163.31M | 0.71% | 341,144 | 70.00M |
| 337 | KZIA | Kazia Therapeutics Limited | 162.55M | -0.52% | 65,110 | 1.27M |
| 338 | HURA | TuHURA Biosciences, Inc. | 161.81M | 5.17% | 287,703 | - |
| 339 | PYXS | Pyxis Oncology, Inc. | 161.54M | -1.15% | 259,638 | 13.86M |
| 340 | KRRO | Korro Bio, Inc. | 160.81M | -0.62% | 31,672 | 3.84M |
| 341 | ANTX | AN2 Therapeutics, Inc. | 158.56M | 3.16% | 203,623 | - |
| 342 | PLX | Protalix BioTherapeutics, Inc. | 157.11M | 2.09% | 1,754,437 | 76.38M |
| 343 | SPRB | Spruce Biosciences, Inc. | 156.73M | 2.36% | 34,667 | 697.00K |
| 344 | MENS | Jyong Biotech Ltd. | 156.26M | -2.78% | 25,203 | - |
| 345 | MOLN | Molecular Partners AG | 150.18M | -0.50% | 3,838 | 856.30K |
| 346 | GALT | Galectin Therapeutics Inc. | 150.09M | 1.33% | 306,217 | - |
| 347 | EQ | Equillium, Inc. | 147.32M | 2.64% | 254,682 | 4.39M |
| 348 | AGEN | Agenus Inc. | 145.38M | 1.74% | 414,703 | 123.87M |
| 349 | GNLX | Genelux Corporation | 143.44M | 8.75% | 219,989 | 8.00K |
| 350 | SPRO | Spero Therapeutics, Inc. | 142.44M | -3.15% | 502,007 | 66.80M |
| 351 | AARD | Aardvark Therapeutics, Inc. | 141.26M | 5.97% | 116,010 | - |
| 352 | GUTS | Fractyl Health, Inc. | 141.20M | 21.25% | 7,548,373 | 3.00K |
| 353 | CNTB | Connect Biopharma Holdings Limited | 140.74M | -7.09% | 168,056 | 233.00K |
| 354 | ALPS | Alps Group Inc | 139.78M | 0.30% | 3,455 | 3.74M |
| 355 | VRCA | Verrica Pharmaceuticals Inc. | 138.12M | 12.45% | 198,331 | 37.16M |
| 356 | IPHA | Innate Pharma S.A. | 137.51M | 0.74% | 8,740 | 10.57M |
| 357 | OKUR | OnKure Therapeutics, Inc. | 137.34M | 0.29% | 128,026 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 136.15M | -1.91% | 62,439 | 39.99K |
| 359 | EDSA | Edesa Biotech, Inc. | 130.80M | 10.93% | 189,572 | - |
| 360 | ACOG | Alpha Cognition Inc. | 127.81M | 6.92% | 42,207 | 10.22M |
| 361 | PEPG | PepGen Inc. | 123.12M | 5.95% | 477,505 | - |
| 362 | TTRX | Turn Therapeutics Inc. | 119.15M | 0.50% | 29,681 | - |
| 363 | CRDF | Cardiff Oncology, Inc. | 115.20M | 2.74% | 351,804 | 593.00K |
| 364 | CBUS | Cibus, Inc. | 111.75M | 2.45% | 63,798 | 3.64M |
| 365 | BMEA | Biomea Fusion, Inc. | 111.34M | -2.53% | 471,184 | - |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 110.36M | 0.21% | 91,755 | - |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 109.39M | -5.32% | 2,347,166 | 65.34K |
| 368 | CGTX | Cognition Therapeutics, Inc. | 108.56M | 2.97% | 545,773 | - |
| 369 | RANI | Rani Therapeutics Holdings, Inc. | 108.30M | -1.36% | 510,485 | 1.63M |
| 370 | COYA | Coya Therapeutics, Inc. | 107.67M | 6.99% | 210,314 | 7.94M |
| 371 | ONCY | Oncolytics Biotech Inc. | 103.35M | -1.47% | 407,734 | - |
| 372 | ENGN | enGene Therapeutics Inc. | 103.16M | 6.94% | 2,268,227 | - |
| 373 | SEER | Seer, Inc. | 102.75M | 0.06% | 74,537 | 16.58M |
| 374 | VANI | Vivani Medical, Inc. | 101.33M | 3.07% | 58,401 | - |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 101.04M | -2.05% | 976,207 | - |
| 376 | QTTB | Q32 Bio Inc. | 100.72M | 2.24% | 161,616 | 53.74M |
| 377 | CUE | Cue Biopharma, Inc. | 98.67M | 3.59% | 116,909 | 27.47M |
| 378 | NRXP | NRx Pharmaceuticals, Inc. | 98.61M | 4.01% | 605,608 | 1.23M |
| 379 | ANIX | Anixa Biosciences, Inc. | 97.23M | -1.69% | 82,101 | - |
| 380 | PMN | ProMIS Neurosciences, Inc. | 95.95M | 2.00% | 3,103 | - |
| 381 | LONA | LeonaBio, Inc. | 94.03M | -1.57% | 12,692 | - |
| 382 | RNTX | Rein Therapeutics Inc. | 91.31M | 4.46% | 460,980 | - |
| 383 | NRXS | NeurAxis, Inc. | 90.89M | -4.47% | 144,958 | 4.28M |
| 384 | PTHS | Pelthos Therapeutics Inc. | 88.25M | -3.45% | 40,222 | 16.80M |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 85.93M | 2.91% | 504,244 | 23.14M |
| 386 | OKYO | OKYO Pharma Limited | 85.28M | 0.31% | 9,777 | - |
| 387 | ACET | Adicet Bio, Inc. | 84.43M | 1.13% | 34,199 | - |
| 388 | CSBR | Champions Oncology, Inc. | 84.02M | -3.51% | 10,501 | 57.95M |
| 389 | EXOZ | eXoZymes, Inc. | 83.77M | - | 505 | -700.00 |
| 390 | PYPD | PolyPid Ltd. | 83.01M | -4.61% | 78,535 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 82.39M | 1.85% | 115,443 | - |
| 392 | GOSS | Gossamer Bio, Inc. | 81.65M | 2.14% | 1,767,532 | 48.47M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 80.09M | 0.76% | 186,525 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 78.51M | -3.11% | 13,100 | 4.43M |
| 395 | ANVS | Annovis Bio, Inc. | 77.96M | -1.32% | 593,083 | - |
| 396 | XBIT | XBiotech Inc. | 77.74M | 2.00% | 29,425 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 76.78M | - | 217,054 | - |
| 398 | ICCC | ImmuCell Corporation | 76.54M | 0.95% | 14,109 | 27.64M |
| 399 | MCRB | Seres Therapeutics, Inc. | 75.61M | -1.38% | 22,003 | 1.15M |
| 400 | RLYB | Rallybio Corporation | 74.06M | -0.21% | 112,159 | 858.00K |
| 401 | OSTX | OS Therapies Incorporated | 73.99M | 2.92% | 331,539 | - |
| 402 | FBIO | Fortress Biotech, Inc. | 73.48M | -2.13% | 273,889 | 63.26M |
| 403 | PLRX | Pliant Therapeutics, Inc. | 73.37M | 0.42% | 131,605 | - |
| 404 | PMVP | PMV Pharmaceuticals, Inc. | 70.66M | -6.69% | 623,460 | - |
| 405 | ACTU | Actuate Therapeutics, Inc. | 70.42M | 2.77% | 87,923 | - |
| 406 | PDSB | PDS Biotechnology Corporation | 70.33M | 14.55% | 933,337 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 69.42M | 0.43% | 269,351 | 9.14M |
| 408 | MNOV | MediciNova, Inc. | 67.93M | - | 6,606 | 409.66K |
| 409 | HYFT | MindWalk Holdings Corp. | 64.57M | 1.56% | 79,005 | 20.70M |
| 410 | IBO | Impact BioMedical Inc. | 64.06M | -4.94% | 48,012 | 32.00K |
| 411 | BYSI | BeyondSpring Inc. | 63.32M | 10.79% | 32,320 | 1.88M |
| 412 | IMA | ImageneBio, Inc. | 62.86M | -1.75% | 267,067 | 800.00K |
| 413 | IMMP | Immutep Limited | 62.77M | -2.17% | 319,491 | 5.28M |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 61.79M | 8.82% | 89,090 | - |
| 415 | CING | Cingulate Inc. | 60.58M | 3.24% | 300,976 | - |
| 416 | KALA | KALA BIO, Inc. | 59.86M | 3.21% | 70,638 | - |
| 417 | ENTX | Entera Bio Ltd. | 59.68M | 2.40% | 59,970 | 42.00K |
| 418 | FLNA | Filana Therapeutics, Inc. | 59.66M | 2.92% | 293,102 | - |
| 419 | LIXT | Lixte Biotechnology Holdings, Inc. | 58.67M | -0.39% | 22,685 | - |
| 420 | IBIO | iBio, Inc. | 56.75M | -2.48% | 240,109 | 300.00K |
| 421 | TIL | Instil Bio, Inc. | 55.27M | 0.62% | 19,301 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 54.95M | -3.33% | 16,001 | - |
| 423 | ESLA | Estrella Immunopharma, Inc. | 52.90M | 2.48% | 14,911 | - |
| 424 | HYPD | Hyperion DeFi, Inc. | 51.57M | 5.83% | 361,635 | 813.46K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 51.20M | 0.74% | 158,717 | 22.33M |
| 426 | RADX | Radiopharm Theranostics Limited | 48.61M | 9.37% | 61,466 | 10.86M |
| 427 | XLO | Xilio Therapeutics, Inc. | 46.31M | 0.13% | 16,561 | 53.48M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 45.63M | 2.68% | 17,670 | - |
| 429 | NTRB | Nutriband Inc. | 44.00M | -0.82% | 1,206 | 2.04M |
| 430 | LITS | Lite Strategy, Inc. | 42.92M | -5.58% | 265,421 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 42.12M | -2.78% | 87,382 | - |
| 432 | ALGS | Aligos Therapeutics, Inc. | 41.52M | 3.71% | 100,874 | 4.71M |
| 433 | ATYR | aTyr Pharma, Inc. | 41.38M | -20.41% | 9,769,714 | 190.00K |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 40.53M | - | 65,081 | 90.00K |
| 435 | DARE | Daré Bioscience, Inc. | 40.48M | 5.70% | 375,380 | 1.03M |
| 436 | MREO | Mereo BioPharma Group plc | 40.40M | 2.89% | 1,073,071 | 500.00K |
| 437 | PSTV | Plus Therapeutics, Inc. | 39.32M | -2.05% | 88,908 | 5.21M |
| 438 | INMB | INmune Bio Inc. | 39.21M | 6.12% | 154,799 | 50.00K |
| 439 | RNXT | RenovoRx, Inc. | 38.98M | -0.87% | 104,405 | 1.12M |
| 440 | TVRD | Tvardi Therapeutics, Inc. | 37.24M | -0.25% | 16,914 | - |
| 441 | NNVC | NanoViricides, Inc. | 37.14M | 14.67% | 393,275 | - |
| 442 | VERU | Veru Inc. | 36.59M | 0.44% | 44,220 | 16.89M |
| 443 | NXTC | NextCure, Inc. | 35.39M | 0.31% | 6,023 | - |
| 444 | EVAX | Evaxion A/S | 35.24M | 1.32% | 22,788 | 7.53M |
| 445 | PLUR | Pluri Inc. | 35.18M | -1.13% | 18,329 | 1.34M |
| 446 | CRVO | CervoMed Inc. | 34.91M | - | 12,054 | 4.01M |
| 447 | BOLD | Boundless Bio, Inc. | 34.75M | 3.33% | 103,190 | - |
| 448 | GRCE | Grace Therapeutics, Inc. | 34.51M | -4.29% | 419,777 | - |
| 449 | PTN | Palatin Technologies, Inc. | 32.25M | -12.53% | 23,255 | 8.96M |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 30.31M | 0.32% | 87,017 | 22.00K |
| 451 | QNTM | Quantum BioPharma Ltd. | 30.12M | 9.62% | 103,305 | - |
| 452 | PLRZ | Polyrizon Ltd. | 29.76M | 5.93% | 21,503 | - |
| 453 | APLM | Apollomics, Inc. | 29.71M | -7.66% | 2,226 | 8.84M |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 29.52M | 1.72% | 5,491 | - |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.48M | 1.96% | 55,071 | - |
| 456 | SKYE | Skye Bioscience, Inc. | 29.44M | 3.04% | 206,016 | - |
| 457 | IGC | IGC Pharma, Inc. | 29.21M | -0.27% | 181,284 | 1.11M |
| 458 | LSTA | Lisata Therapeutics, Inc. | 29.17M | -0.92% | 25,533 | 170.00K |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 28.98M | -1.57% | 71,487 | - |
| 460 | SNSE | Sensei Biotherapeutics, Inc. | 28.59M | 1.58% | 35,733 | - |
| 461 | KYNB | Kyntra Bio, Inc. | 28.54M | -2.42% | 2,818 | 7.44M |
| 462 | HOWL | Werewolf Therapeutics, Inc. | 28.43M | -7.44% | 1,125,847 | 1.14M |
| 463 | LTRN | Lantern Pharma Inc. | 27.80M | 20.39% | 798,104 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 27.78M | -2.84% | 10,917 | 14.97M |
| 465 | DYAI | Dyadic International, Inc. | 27.31M | 3.71% | 38,700 | 3.09M |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 27.28M | 2.64% | 5,193 | 14.99M |
| 467 | TPST | Tempest Therapeutics, Inc. | 26.97M | -2.08% | 65,496 | - |
| 468 | ABVC | ABVC BioPharma, Inc. | 26.44M | 1.90% | 74,078 | 797.92K |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 26.15M | 6.19% | 794,603 | 789.00K |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.27M | -1.08% | 158,581 | - |
| 471 | OTLK | Outlook Therapeutics, Inc. | 25.11M | -1.03% | 1,366,805 | 205.70K |
| 472 | MRKR | Marker Therapeutics, Inc. | 23.84M | -0.69% | 46,790 | 3.55M |
| 473 | ALLR | Allarity Therapeutics, Inc. | 23.81M | 1.32% | 55,539 | 320.00K |
| 474 | CELU | Celularity Inc. | 23.51M | 5.01% | 287,957 | 26.55M |
| 475 | SER | Serina Therapeutics, Inc. | 23.24M | -4.29% | 66,803 | 130.00K |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.43M | 1.99% | 135,982 | 570.00K |
| 477 | LGVN | Longeveron Inc. | 21.96M | -0.01% | 253,855 | 1.20M |
| 478 | AEON | AEON Biopharma, Inc. | 21.83M | -5.68% | 110,380 | - |
| 479 | GRDX | GridAI Technologies Corp. | 20.77M | - | 40,262 | - |
| 480 | OSRH | OSR Holdings, Inc. | 20.33M | -4.41% | 1,622,940 | 2.91M |
| 481 | XCUR | Exicure, Inc. | 20.14M | -2.47% | 8,484 | 500.00K |
| 482 | QNCX | Quince Therapeutics, Inc. | 20.05M | -2.38% | 360,721 | - |
| 483 | CRIS | Curis, Inc. | 19.91M | -9.52% | 434,625 | 9.44M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 19.77M | 1.63% | 26,942 | - |
| 485 | ICU | SeaStar Medical Holding Corporation | 19.03M | -1.65% | 35,674 | 1.23M |
| 486 | LPCN | Lipocine Inc. | 18.46M | -1.29% | 26,104 | 2.00M |
| 487 | PASG | Passage Bio, Inc. | 17.90M | 10.93% | 74,052 | - |
| 488 | COCP | Cocrystal Pharma, Inc. | 17.78M | -1.53% | 52,852 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 17.52M | 5.45% | 521,882 | 3.94M |
| 490 | NCEL | NewcelX Ltd. | 17.44M | -2.70% | 6,472 | - |
| 491 | TRAW | Traws Pharma, Inc. | 17.37M | 1.79% | 1,086,547 | 2.79M |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 16.90M | 5.78% | 38,459 | - |
| 493 | INAB | IN8bio, Inc. | 15.85M | 0.63% | 11,236 | - |
| 494 | ERNA | Ernexa Therapeutics Inc. | 15.09M | 7.74% | 1,611,238 | 1,000.00 |
| 495 | TOVX | Theriva Biologics, Inc. | 14.95M | 1.18% | 1,256,951 | 300.00K |
| 496 | LEXX | Lexaria Bioscience Corp. | 14.63M | 2.34% | 182,359 | 368.00K |
| 497 | GNTA | Genenta Science S.p.A. | 14.63M | 1.14% | 54,494 | - |
| 498 | HIND | Vyome Holdings, Inc. | 13.69M | -1.52% | 34,562 | 319.71K |
| 499 | CYCN | Cyclerion Therapeutics, Inc. | 13.44M | - | 97,041 | 2.07M |
| 500 | BLRX | BioLineRx Ltd. | 13.43M | -1.28% | 14,653 | 1.18M |